Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)

Trials

Volumn 13, Issue , 2012, Pages

  van der Sluis, Pieter C ^a   Ruurda, Jelle P ^a   van der Horst, Sylvia ^a   Verhage, Roy J J ^a   Besselink, Marc G H ^a   Prins, Margriet J D ^a   Haverkamp, Leonie ^a   Schippers, Carlo ^a   Rinkes, Inne HM Borel ^a   Joore, Hans C A ^a   ten Kate, Fiebo J W ^a   Koffijberg, Hendrik ^a   Kroese, Christiaan C ^a   van Leeuwen, Maarten S ^a   Lolkema, Martijn P J K ^a   Reerink, Onne ^a   Schipper, Marguerite E I ^a   Steenhagen, Elles ^a   Vleggaar, Frank P ^a   Voest, Emile E ^a   Siersema, Peter D ^a   van Hillegersberg, Richard ^a   more..

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; METHYLPREDNISOLONE; METRONIDAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLEEDING; CANCER SURVIVAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FOLLOW UP; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; INFORMED CONSENT; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LENGTH OF STAY; MINIMALLY INVASIVE SURGERY; MORTALITY; OUTCOME ASSESSMENT; PEROPERATIVE COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; ROBOTICS; SHORT COURSE THERAPY; SURGICAL APPROACH; THORACOLAPAROSCOPIC ESOPHAGECTOMY; THORAX SURGERY; TRANSTHORACIC ESOPHAGECTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CLINICAL PROTOCOLS; COST-BENEFIT ANALYSIS; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LAPAROSCOPY; LENGTH OF STAY; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; NETHERLANDS; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RESEARCH DESIGN; RISK FACTORS; ROBOTICS; SURGERY, COMPUTER-ASSISTED; THORACOSCOPY; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84870222976     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-13-230     Document Type: Article

References (30)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Omloo JMT, Lagarde SM, Hulscher JBF, Reitsma JB, Fockens P, van Dekken H, ten Kate FJW, Obertop H, Tilanus HW, Lanschot JJB. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus. Ann Surg 2007, 246:992-1001. 10.1097/SLA.0b013e31815c4037, 18043101.
3. Mariette C, Piessen G, Triboulet JP. Therapeutic strategies in oesophageal carcinoma: role of surgery and other modalities. Lancet Oncol 2007, 8:545-553. 10.1016/S1470-2045(07)70172-9, 17540306.
4. Burmeister BH, Smithers BM, Gebski V, Fitzgerald L, Simes RJ, Devitt P, Ackland S, Gotley DC, Joseph D, Millar J, North J, Walpole ET, Denham JW, . Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. Lancet Oncol 2005, 6:659-668. 10.1016/S1470-2045(05)70288-6, 16129366, Trans-Tasman Radiation Oncology Group; Australasian Gastro-Intestinal Trials Group.
5. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J, . Australasian Gastro-Intestinal Trials Group Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007, 8:226-234. 10.1016/S1470-2045(07)70039-6, 17329193, Australasian Gastro-Intestinal Trials Group.
6. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002, 347:1662-1669. 10.1056/NEJMoa022343, 12444180.
7. Boone J, Livestro DP, Elias SG, Borel Rinkes IH, van Hillegersberg R. International survey on esophageal cancer: part I surgical techniques. Dis Esophagus 2009, 22:195-202. 10.1111/j.1442-2050.2008.00929.x, 19191856.
8. Verhage RJ, Hazebroek EJ, Boone J, Van Hillegersberg R. Minimally invasive surgery compared to open procedures in esophagectomy for cancer: a systematic review of the literature. Minerva Chir 2009, 64:135-146.
9. Singh RK, Pham TH, Diggs BS, Perkins S, Hunter JG. Minimally invasive esophagectomy provides equivalent oncologic outcomes to open esophagectomy for locally advanced (stage II or III) esophageal carcinoma. Arch Surg 2011, 146:711-714. 10.1001/archsurg.2011.146, 21690448.
10. Nafteux P, Moons J, Coosemans W, Decaluwé H, Decker G, De Leyn P, Van Raemdonck D, Lerut T. Minimally invasive oesophagectomy: a valuable alternative to open oesophagectomy for the treatment of early oesophageal and gastro-oesophageal junction carcinoma. Eur J Cardiothorac Surg 2011, 40:1455-1463. discussion 1463-1464.
11. Safranek PM, Cubitt J, Booth MI, Dehn TC. Review of open and minimal access approaches to oesophagectomy for cancer. Br J Surg 2010, 97:1845-1853. 10.1002/bjs.7231, 20922782.
12. Gemmill EH, McCulloch P. Systematic review of minimally invasive resection for gastro-oesophageal cancer. Br J Surg 2007, 94:1461-1467. 10.1002/bjs.6015, 17973268.
13. van Hillegersberg R, Boone J, Draaisma WA, Broeders IA, Giezeman MJ, Borel Rinkes IH. First experience with robot-assisted thoracoscopic esophagolymphadenectomy for esophageal cancer. Surg Endosc 2006, 20:1435-1439. 10.1007/s00464-005-0674-8, 16703427.
14. Boone J, Schipper ME, Moojen WA, Borel Rinkes IH, Cromheecke GJ, van Hillegersberg R. Robot-assisted thoracoscopic oesophagectomy for cancer. Br J Surg 2009, 96:878-886. 10.1002/bjs.6647, 19591168.
15. The Declaration of Helsinki. http://www.wma.net/en/30publications/10policies/b3.
16. The Good Clinical Practice Guidelines. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002874.pdf.
17. Vereniging Integrale Kankercentra. Richtlijn oesofaguscarcinoom. http://www.oncoline.nl.
18. Sato N, Koeda K, Ikeda K, Kimura Y, Aoki K, Iwaya T, Akiyama Y, Ishida K, Saito K, Endo S. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg 2002, 236:184-190. 10.1097/00000658-200208000-00006, 1422564, 12170023.
19. Tuǧrul M, Camci E, Karadeniz H, Sentürk M, Pembeci K, Akpir K. Comparison of volume controlled with pressure controlled ventilation during one-lung anaesthesia. Br J Anaesth 1997, 79:306-310. 10.1093/bja/79.3.306, 9389846.
20. Naruke T, Tsuchiya R, Kondo H, Nakayama H, Asamura H. Lymph node sampling in lung cancer: how should it be done?. Eur J Cardiothorac Surg 1999, 16(Suppl 1):S17-S24.
21. Boone J, Rinkes IH, van Hillegersberg R. Gastric conduit staple line after esophagectomy: to oversew or not?. J Thorac Cardiovasc Surg 2006, 132:1491-1492. 10.1016/j.jtcvs.2006.08.017, 17140994.
22. Boone J, van Hillegersberg R. The azygos vein: to resect or not?. J Gastrointest Surg 2008, 12:2246-2247. 10.1007/s11605-008-0608-6, 18677537.
23. Dindo D, Demartines N, Clavien P. Classification of surgical complications a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004, 240:205-213. 10.1097/01.sla.0000133083.54934.ae, 1360123, 15273542.
24. Sobin LH, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumors 2009, Oxford: Wiley-Blackwell, 7.
25. Verhage RJ, Zandvoort HJ, ten Kate FJ, van Hillegersberg R. How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus. Am J Surg Pathol 2011, 35:919-926. 10.1097/PAS.0b013e31821a5692, 21566512.
26. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, Roussel A, Jacob JH, Segol P, Samama G. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994, 73:2680-2686. 10.1002/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C, 8194005.
27. Ruurda JP, van Vroonhoven TJ, Broeders IA. Robot-assisted surgical systems: a new era in laparoscopic surgery. Ann R Coll Surg Engl 2002, 84:223-226. 10.1308/003588402320439621, 2504216, 12215022.
28. Clark J, Sodergren MH, Purkayastha S, Mayer EK, James D, Athanasiou T, Yang GZ, Darzi A. The role of robotic assisted laparoscopy for oesophagogastric oncological resection; an appraisal of the literature. Dis Esophagus 2011, 24:240-250. 10.1111/j.1442-2050.2010.01129.x, 21073622.
29. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, Gisbertz SS, Klinkenbijl JH, Hollmann MW, de Lange ES, Bonjer HJ, van der Peet DL, Cuesta MA. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012, 379:1887-1892. 10.1016/S0140-6736(12)60516-9, 22552194.
30. Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 2012, 256:95-103. 10.1097/SLA.0b013e3182590603, 22668811.